TY  - RPRT
TI  - Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group.
AU  - A Le Cesne
AU  - I Judson
AU  - D Crowther
AU  - S Rodenhuis
AU  - H J Keizer
AU  - Q Van Hoesel
AU  - J Y Blay
AU  - J Frisch
AU  - M Van Glabbeke
AU  - C Hermans
AU  - A Van Oosterom
AU  - T Tursz
AU  - J Verweij
PY  - 2000
DO  - 10.1200/jco.2000.18.14.2676
UR  - https://pubmed.ncbi.nlm.nih.gov/10894866/
ID  - 10894866
ER  -